title: Telomere length in peripheral blood granulocytes reflects response to treatment with imatinib in patients with chronic myeloid leukemia.
authors.forename: Tim H
authors.initials: TH
authors.lastname: Brümmendorf
authors.forename: Inci
authors.initials: I
authors.lastname: Ersöz
authors.forename: Ulrike
authors.initials: U
authors.lastname: Hartmann
authors.forename: Kerol
authors.initials: K
authors.lastname: Bartolovic
authors.forename: Stefan
authors.initials: S
authors.lastname: Balabanov
authors.forename: Alexandra
authors.initials: A
authors.lastname: Wahl
authors.forename: Peter
authors.initials: P
authors.lastname: Paschka
authors.forename: Sebastian
authors.initials: S
authors.lastname: Kreil
authors.forename: Tanja
authors.initials: T
authors.lastname: Lahaye
authors.forename: Ute
authors.initials: U
authors.lastname: Berger
authors.forename: Harald
authors.initials: H
authors.lastname: Gschaidmeier
authors.forename: Carsten
authors.initials: C
authors.lastname: Bokemeyer
authors.forename: Rüdiger
authors.initials: R
authors.lastname: Hehlmann
authors.forename: Klaus
authors.initials: K
authors.lastname: Dietz
authors.forename: Peter M
authors.initials: PM
authors.lastname: Lansdorp
authors.forename: Lothar
authors.initials: L
authors.lastname: Kanz
authors.forename: Andreas
authors.initials: A
authors.lastname: Hochhaus
mesh_terms: D001549:Benzamides; D015415:Biomarkers; D006098:Granulocytes / Q000648:ultrastructure*; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D016615:Telomere / Q000378:metabolism / Q000648:ultrastructure*; D016896:Treatment Outcome
chemical_list: D001549:Benzamides; D015415:Biomarkers; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate